BioLine RX Ltd (BLRX.TA)

BLRX.TA on Tel Aviv Stock Exchange

67.00
10:24am EDT
Price Change (% chg)

-0.90₪ (-1.32%)
Prev Close
68.00₪
Open
67.00₪
Day's High
68.40₪
Day's Low
66.90₪
Volume
406,422
Avg. Vol
619,605
52-wk High
117.00₪
52-wk Low
63.00₪

BLRX.TA

Chart for BLRX.TA

About

BioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates under development consist of BL-1020 that is in Phase II/III clinical trials to improve cognitive function in... (more)
No analyst recommendations are available for BLRX.TA.

Overall

Beta: 1.92
Market Cap (Mil.): ₪231.98
Shares Outstanding (Mil.): 341.15
Dividend: --
Yield (%): --

Financials

  BLRX.TA Industry Sector
P/E (TTM): -- 105.76 36.12
EPS (TTM): -0.47 -- --
ROI: -99.86 -0.63 18.15
ROE: -100.08 -1.65 18.97
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks